Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PEACEHEALTH

NPI: 1346237971 · EUGENE, OR 97401 · General Acute Care Hospital · NPI assigned 09/29/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SEIRER, JEFFREY controls 14+ related entities in our dataset. Read more

$13.35M
Total Medicaid Paid
147,919
Total Claims
126,242
Beneficiaries
50
Codes Billed
2018-01
First Month
2023-11
Last Month

Provider Details

Authorized OfficialSEIRER, JEFFREY (SYS VP FIN INTEGRIT/CONTROLLER)
NPI Enumeration Date09/29/2005

Related Entities

Other providers sharing the same authorized official: SEIRER, JEFFREY

ProviderCityStateTotal Paid
PEACEHEALTH VANCOUVER WA $81.65M
PEACEHEALTH LONGVIEW WA $48.29M
PEACEHEALTH BELLINGHAM WA $47.27M
PEACEHEALTH SPRINGFIELD OR $30.72M
PEACEHEALTH VANCOUVER WA $2.56M
PEACEHEALTH EUGENE OR $1.84M
PEACEHEALTH FRIDAY HARBOR WA $1.06M
PEACEHEALTH VANCOUVER WA $1.00M
PEACEHEALTH VANCOUVER WA $814K
PEACEHEALTH SPRINGFIELD OR $395K
PEACEHEALTH BELLINGHAM WA $77K
PEACEHEALTH KELSO WA $13K
PEACEHEALTH KETCHIKAN AK $9K
PEACEHEALTH EUGENE OR $0.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 26,993 $2.49M
2019 25,766 $2.67M
2020 15,718 $1.54M
2021 19,855 $1.78M
2022 28,331 $2.40M
2023 31,256 $2.46M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 21,889 19,342 $5.72M
99283 Emergency department visit for the evaluation and management, moderate severity 20,165 18,003 $3.48M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 8,956 7,718 $3.16M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,727 2,381 $336K
90853 Group psychotherapy (other than of a multiple-family group) 1,471 174 $174K
S9480 Intensive outpatient psychiatric services, per diem 701 102 $139K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,077 964 $109K
96361 Intravenous infusion, hydration; each additional hour 1,838 1,497 $77K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,647 1,437 $47K
96375 Therapeutic injection; each additional sequential IV push 641 546 $30K
71046 Radiologic examination, chest; 2 views 333 289 $15K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 578 174 $11K
71045 Radiologic examination, chest; single view 178 157 $10K
97530 Therapeutic activities, direct patient contact, each 15 minutes 300 97 $9K
74177 Computed tomography, abdomen and pelvis; with contrast material 27 27 $8K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 251 67 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 28 26 $4K
90832 Psychotherapy, 30 minutes with patient 21 12 $3K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 26 15 $3K
80053 Comprehensive metabolic panel 31,151 26,855 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 18 15 $2K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 179 81 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 33,333 28,716 $1K
11720 82 59 $246.79
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 357 308 $209.38
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,430 3,821 $176.29
97535 Self-care/home management training, each 15 minutes 24 12 $130.98
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 233 216 $129.35
G0127 Trimming of dystrophic nails, any number 138 85 $125.84
36415 Collection of venous blood by venipuncture 4,145 3,604 $82.38
11721 19 12 $54.94
J1885 Injection, ketorolac tromethamine, per 15 mg 1,055 857 $42.17
81001 3,939 3,439 $37.62
80048 Basic metabolic panel (calcium, ionized) 965 813 $20.30
84703 1,298 1,173 $16.26
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 81 70 $10.80
83690 1,248 1,129 $9.82
80305 335 277 $9.00
84484 429 273 $9.00
84460 346 301 $3.71
84450 346 301 $3.63
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 116 91 $0.00
87631 308 289 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 154 139 $0.00
83605 37 27 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 17 14 $0.00
84443 Thyroid stimulating hormone (TSH) 81 64 $0.00
83735 157 133 $0.00
J1170 Injection, hydromorphone, up to 4 mg 30 27 $0.00
87086 Culture, bacterial; quantitative colony count, urine 14 13 $0.00